# Impact of Dysport on PMFF Donor Scar

> **NCT07720726** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Skin Cancer Excision Site
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Melanoma

## Interventions

- **DRUG:** Abobotulinumtoxin-A
- **OTHER:** Control- Saline injection

## Key facts

- **NCT ID:** NCT07720726
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-14
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07720726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07720726, "Impact of Dysport on PMFF Donor Scar". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07720726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*